Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES
β Scribed by Masaru Matsui; Jennifer Weaver; Amanda E.I Proudfoot; Jerome R Wujek; Tao Wei; Edward Richer; Bruce D Trapp; Ashwin Rao; Richard M Ransohoff
- Book ID
- 114137652
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 351 KB
- Volume
- 128
- Category
- Article
- ISSN
- 0165-5728
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract During immuneβmediated demyelinating lesions, the endocannabinoid system is involved in the pathogenesis of both neuroinflammation and neurodegeneration through different mechanisms. Here we explored the cellular distribution of the CB1 receptor (CB1R) in the central nervous system (CNS
## Abstract Hepatocyte growth factor (HGF) is a pleiotropic cytokine able to evoke a wide array of cellular responses including proliferation, migration, and survival through activation of its receptor cβmet. Various types of leukocytes have been described to express cβmet suggesting that HGF/cβmet
Upregulated expression of the low-affinity neurotrophin receptor (p75) in the central nervous system (CNS) during experimental autoimmune encephalomyelitis (EAE) has recently been demonstrated. To investigate whether p75 plays a role in disease pathogenesis, we adopted a gene therapy approach, utili